Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:37:03 EST Wed 17 Dec 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:CNSP - CNS PHARMACEUTICALS INC - https://cnsp-rcps.ca
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CNSP - Q0.17.06·9.220.17.39+0.12341.76.9416487.23  7.6449  7.04114.00  4.9316:10:04Nov 1715 min RT 2¢

Recent Trades - Last 10 of 648
Time ETExPriceChangeVolume
16:10:04Q7.390.301
16:04:05Q7.390.301
16:00:01Q7.390.302
16:00:01Q7.390.303
16:00:01Q7.390.1234100
15:59:09Q7.250.1670
15:59:09Q7.270.181
15:59:09Q7.390.309
15:56:48Q7.2740.1841
15:47:19Q7.10-0.1666111

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-11-17 08:35U:CNSPNews ReleaseCNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
2025-11-10 08:45U:CNSPNews ReleaseCNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting
2025-09-03 09:15U:CNSPNews ReleaseCNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
2025-08-27 08:00U:CNSPNews ReleaseIBN Announces Latest Episode of The BioMedWire Podcast Featuring John Climaco, CEO of CNS Pharmaceuticals Inc.
2025-08-15 08:05U:CNSPNews ReleaseCNS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Update
2025-08-14 09:15U:CNSPNews ReleaseCNS Pharmaceuticals to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
2025-07-22 08:45U:CNSPNews ReleaseCNS Pharmaceuticals to Participate in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference
2025-07-22 08:40U:CNSPNews ReleaseJTC Team Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference Now Live
2025-07-18 08:00U:CNSPNews ReleaseCNS Pharmaceuticals Announces Reverse Stock Split
2025-07-09 09:33U:CNSPNews ReleaseCNS Pharmaceuticals Participates in Virtual Investor CEO Connect Segment
2025-06-24 09:15U:CNSPNews ReleaseCNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment Discussing Glioblastoma Multiforme (GBM) and Lead Product Candidate TPI 287
2025-06-05 08:05U:CNSPNews ReleaseCNS Pharmaceuticals' Chief Medical Officer, Sandra Silberman, MD, PhD to Present at the 2025 Brain Tumor Biotech Summit
2025-05-16 08:06U:CNSPNews ReleaseCNS Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Update
2025-05-13 09:37U:CNSPNews ReleaseCNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
2025-05-13 07:02U:CNSPNews ReleaseCNS Pharmaceuticals Acquires Orphan Drug Designation for Novel, Late Stage Abeotaxane, TPI 287
2025-04-01 08:07U:CNSPNews ReleaseCNS Pharmaceuticals Reports Full Year 2024 Financial Results
2025-03-25 08:02U:CNSPNews ReleaseCNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme
2025-02-26 09:06U:CNSPNews ReleaseCNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing
2025-02-20 09:03U:CNSPNews ReleaseCNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum
2025-02-19 09:04U:CNSPNews ReleaseCNS Pharmaceuticals, Inc. Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference